| scholarly article | Q13442814 |
| P50 | author | Carlos M. Palmeira | Q47503993 |
| Anabela Pinto Rolo | Q51064473 | ||
| P2093 | author name string | Kendall B Wallace | |
| P2860 | cites work | Induction of the mitochondrial permeability transition as a mechanism of liver injury during cholestasis: a potential role for mitochondrial proteases | Q77136049 |
| The effect of idebenone, a coenzyme Q analogue, on hydrophobic bile acid toxicity to isolated rat hepatocytes and hepatic mitochondria | Q77313291 | ||
| Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications | Q77598543 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy | Q28280478 | ||
| Chapter 4 Preparation of Isolated Rat Liver Cells | Q29616604 | ||
| URSO-panacea or placebo? | Q33873354 | ||
| Mitochondrial targets of drug toxicity | Q33932157 | ||
| Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium | Q34109467 | ||
| Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes | Q34260290 | ||
| Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes | Q35824326 | ||
| Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis | Q36235778 | ||
| A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation | Q37383640 | ||
| The mitochondrial permeability transition. | Q40462729 | ||
| Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids. | Q41341706 | ||
| Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids | Q41668171 | ||
| Effects of bile salts on the plasma membranes of isolated rat hepatocytes | Q41900837 | ||
| Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture | Q42276877 | ||
| Interactions of combined bile acids on hepatocyte viability: cytoprotection or synergism. | Q43868844 | ||
| Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats | Q43997238 | ||
| Antioxidant defenses in the bile duct-ligated rat | Q46424638 | ||
| Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. | Q51624442 | ||
| Protection by acidotic pH and fructose against lethal injury to rat hepatocytes from mitochondrial inhibitors, ionophores and oxidant chemicals. | Q52484678 | ||
| Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis | Q58376775 | ||
| Bile Acids Affect Liver Mitochondrial Bioenergetics: Possible Relevance for Cholestasis Therapy | Q60398074 | ||
| Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei | Q60895762 | ||
| Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar-nucleotides in animal cells | Q67868807 | ||
| Reduced activity of the electron transport chain in liver mitochondria isolated from rats with secondary biliary cirrhosis | Q68134833 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography | Q70976314 | ||
| Hepatic levels of bile acids in end-stage chronic cholestatic liver disease | Q71665237 | ||
| A rapid beta-NADH-linked fluorescence assay for lactate dehydrogenase in cellular death | Q71690129 | ||
| Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria | Q72862935 | ||
| Glutathione status of isolated rat hepatocytes affects bile acid-induced cellular necrosis but not apoptosis | Q73598613 | ||
| P433 | issue | 1 | |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 127-132 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Biochimica et Biophysica Acta | Q864239 |
| P1476 | title | Mitochondrially mediated synergistic cell killing by bile acids | |
| P478 | volume | 1637 |
| Q42709815 | A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development |
| Q58579858 | Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome |
| Q58560352 | Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers |
| Q38059807 | Anticancer steroids: linking natural and semi-synthetic compounds |
| Q36006541 | Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis |
| Q39657434 | Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development |
| Q36972843 | NIM811 (N-methyl-4-isoleucine cyclosporine), a mitochondrial permeability transition inhibitor, attenuates cholestatic liver injury but not fibrosis in mice |
| Q37309043 | Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction |
| Q34272924 | SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function |
| Q24627930 | SRT1720 improves survival and healthspan of obese mice |
| Q57115299 | Serum Metabonomics Analysis of Liver Failure Treated by Nonbioartificial Liver Support Systems |
| Q39896739 | Toxicity of peroxisomal C27-bile acid intermediates |
| Q44314505 | Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage. |
Search more.